Publications by authors named "Nicholas A Butowski"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,515

Total Likes

271

Extended Reach

1,473,841

Social Features

146
C
Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.
Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, Sebastian M Waszak, Stefan R Sweha, Nicholas A Butowski

Cancer Discov· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses.
Calixto-Hope G Lucas, Nadeem N Al-Adli, Jacob S Young, Rohit Gupta, Ramin A Morshed, Nicholas A Butowski

Neuro Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survival.
Eduardo Rodriguez Almaraz, Geno A Guerra, Nadeem N Al-Adli, Jacob S Young, Abraham Dada, Nicholas A Butowski

Neurooncol Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma: A Randomized Clinical Trial.
Jann N Sarkaria, Karla V Ballman, Sani H Kizilbash, Erik P Sulman, Caterina Giannini, Nicholas A Butowski

JAMA Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automatic Brain Tissue and Lesion Segmentation and Multi-Parametric Mapping of Contrast-Enhancing Gliomas without the Injection of Contrast Agents: A Preliminary Study.
Jing Liu, Angela Jakary, Javier E Villanueva-Meyer, Nicholas A Butowski, David Saloner

Cancers (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas.
Atsuro Saijo, Hirokazu Ogino, Nicholas A Butowski, Meghan R Tedesco, David Gibson

Neuro Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
Sara Hadad, Rohit Gupta, Nancy Ann Oberheim Bush, Jennie W Taylor, Javier E Villanueva-Meyer, Nicholas A Butowski

Acta Neuropathol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative analysis of promoter methylation in glioblastoma suggests nonlinear prognostic effect.
David Gibson, Akshay Ravi, Eduardo Rodriguez, Susan Chang, Nancy Oberheim Bush, Nicholas A Butowski

Neurooncol Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomes.
Yalan Zhang, Calixto-Hope G Lucas, Jacob S Young, Ramin A Morshed, Lucie McCoy, Nicholas A Butowski

Neuro Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.
Calixto-Hope G Lucas, Emily A Sloan, Rohit Gupta, Jasper Wu, Drew Pratt, Nicholas A Butowski

Acta Neuropathol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK 4/6 inhibitors for the treatment of meningioma.
Jacob S Young, Reilly L Kidwell, Allison Zheng, Alex F Haddad, Manish K Aghi, Nicholas A Butowski

Front Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study.
Andrew B Lassman, Juan Manuel Sepúlveda-Sánchez, Timothy F Cloughesy, Miguel J Gil-Gil, Vinay K Puduvalli, Nicholas A Butowski

Clin Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance).
Evanthia Galanis, S Keith Anderson, Erin Twohy, Nicholas A Butowski, Adilia Hormigo

Neurooncol Adv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas.
Hirokazu Ogino, Jennie W Taylor, Takahide Nejo, David Gibson, Payal B Watchmaker, Nicholas A Butowski

J Clin Invest· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma.
Nancy Ann Oberheim Bush, Jacob S Young, Yalan Zhang, Cecilia L Dalle Ore, Annette M Molinaro, Nicholas A Butowski

J Neurooncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mouse models of glioblastoma for the evaluation of novel therapeutic strategies.
Alexander F Haddad, Jacob S Young, Dominic Amara, Mitchel S Berger, David R Raleigh, Nicholas A Butowski

Neurooncol Adv· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of diffusion MRI as a biomarker for efficacy using randomized phase III trial of bevacizumab with or without VB-111 in recurrent glioblastoma.
Benjamin M Ellingson, Kunal Patel, Chencai Wang, Catalina Raymond, Andrew Brenner, Nicholas A Butowski

Neurooncol Adv· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective prediction of clinical drug response in high-grade gliomas using an ex vivo 3D cell culture assay.
Stephen Shuford, Lindsay Lipinski, Ajay Abad, Ashley M Smith, Melissa Rayner, Nicholas A Butowski

Neurooncol Adv· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment.
Maciej M Mrugala, Quinn T Ostrom, Shelley M Pressley, Jennie W Taylor, Alissa A Thomas, Nicholas A Butowski

Neurooncol Adv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial. Chronic convection-enhanced delivery: the next frontier in regional drug infusion for glioblastoma.
Nicholas A Butowski, John R Bringas, Krystof S Bankiewicz, Manish K Aghi

J Neurosurg· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).
Timothy F Cloughesy, Andrew Brenner, John F de Groot, Nicholas A Butowski, Leor Zach

Neuro Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survival.
Christopher H Chapman, Jared H Hara, Annette M Molinaro, Jennifer L Clarke, Nancy Ann Oberheim Bush, Nicholas A Butowski

Neurooncol Pract· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attitudes toward fertility and fertility preservation in women with glioma.
Rachel K Stiner, Jennifer L Clarke, Nikita Sinha, Jessica Chan, Joseph M Letourneau, Nicholas A Butowski

Neurooncol Pract· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.
Timothy F Cloughesy, Aaron Y Mochizuki, Joey R Orpilla, Willy Hugo, Alexander H Lee, Nicholas A Butowski

Nat Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis